The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 Apr 2017 15:06

RNS Number : 3649C
Motif Bio PLC
12 April 2017
 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Motif Bio plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

CHANGE IN NATURE : RETURN OF LOANED SHARES

3. Full name of person(s) subject to thenotification obligation: iii

Aviva plc & its subsidiaries

4. Full name of shareholder(s)  (if different from 3.):iv

Registered Holder:

 

Available on Request 3,444*

 

Chase (GA Group) Nominees Limited 4,854,076*

 

HSBC Global Custody Nominee (UK) Limited 1,038,396*

*denotes direct interest

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

10 April 2017

6. Date on which issuer notified:

11 April 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

 

3% change at Direct Interest Level (Box 8A)

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

Ordinary Shares

 

GB00BVVT4H71

6,895,922*

6,895,922*

5,895,916

5,895,916

** Not Disclosable

3.01%

** Not Disclosable

 

*Includes Right to Recall Loaned Shares (1,200,000)

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

RIGHT TO RECALL LOANED SHARES

N/A

N/A

 

1,000,006*

 

*Direct interest

 

0.51%

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,895,922

3.52%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited & Friends Provident International Limited, with the following chain of controlled undertakings:-

 

Aviva Investors Global Services Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

· Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

Friends Provident International Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Friends Provident International Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

 

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Figures are based on the revised total number of voting rights of 195,885,228 as per the Company's 'Issue of Equity and Total Voting Rights' announcement of 9 January 2017.

 

** Although not reportable, as per DTR5.1.5,the non-disclosable (indirect) position is currently 2,028,725 shares, and is included here in the interests of transparency.

 

14. Contact name:

Neil Whittaker, Aviva plc

15. Contact telephone number:

01603 684420

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFISSFIFLID
Date   Source Headline
15th Jun 20217:00 amRNSCancellation - Motif Bio plc
14th Jun 202112:24 pmRNSResult of General Meeting
11th Jun 20212:59 pmRNSGeneral Meeting – Dial in Details
2nd Jun 20219:32 amRNSUpdate on Share Consolidation & Admission Warrants
26th May 20214:00 pmRNSSchedule One - Motif Bio plc
26th May 20213:00 pmRNSUpdate on Proposed Reverse Takeover
10th May 20217:00 amRNS2020 Annual Report and Accounts
29th Mar 20217:00 amRNSUpdate re proposed Reverse Takeover
26th Feb 20217:00 amRNSUpdate re Motif BioSciences Inc
27th Jan 20217:00 amRNSUpdate re proposed Reverse Takeover
5th Jan 20217:00 amRNSBusiness Update
12th Oct 20207:00 amRNSHalf-year Report
30th Sep 20202:27 pmRNSResult of AGM
23rd Sep 20207:00 amRNSNotification of Interim Results
9th Sep 20207:00 amRNSAnnual Report and Accounts & Notice of AGM
1st Sep 20207:00 amRNSFinal Results
29th Jul 20207:30 amRNSSuspension - Motif Bio Plc
29th Jul 20207:30 amRNSSuspension of Trading on AIM
28th Jul 20204:41 pmRNSSecond Price Monitoring Extn
28th Jul 20204:36 pmRNSPrice Monitoring Extension
22nd Jun 20207:00 amRNSDelay in publication of Final Results
17th Jun 20204:41 pmRNSSecond Price Monitoring Extn
17th Jun 20204:36 pmRNSPrice Monitoring Extension
12th Jun 202012:41 pmRNSHolding(s) in Company
5th Jun 20201:55 pmRNSHolding(s) in Company
4th Jun 20201:32 pmRNSHolding(s) in Company
2nd Jun 20204:42 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
1st Jun 20207:00 amRNSBusiness update & Appointment of Strategic Adviser
29th May 20207:00 amRNSTotal Voting Rights
21st May 202012:20 pmRNSHolding(s) in Company
19th May 202010:30 amRNSHolding(s) in Company
15th May 20207:00 amRNSExercise of Warrants
12th May 20205:02 pmRNSHolding(s) in Company
5th May 20207:00 amRNSPlacing to raise £650,000
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSDirectorate Changes & Corporate Update
15th Apr 20204:41 pmRNSSecond Price Monitoring Extn
15th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:37 pmRNSPrice Monitoring Extension
14th Apr 20201:21 pmRNSStmnt re Share Price Movement
9th Apr 20204:40 pmRNSSecond Price Monitoring Extn
9th Apr 20204:36 pmRNSPrice Monitoring Extension
9th Apr 202012:08 pmRNSSecond Price Monitoring Extn
9th Apr 202012:03 pmRNSPrice Monitoring Extension
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20205:30 pmRNSMotif Bio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.